About Audrey Burton-Bethke

Articles by Audrey Burton-Bethke

HealthTree 2.0 Pillar Three: A Powerful Patient Data Portal
Sep 10, 2023
HealthTree 2.0 Pillar Three: A Powerful Patient Data Portal
Sep 10, 2023
HealthTree 2.0 Pillar One: Personalized, Lifetime Support and Education
Sep 07, 2023
HealthTree 2.0 Pillar One: Personalized, Lifetime Support and Education
Sep 07, 2023
HealthTree 2.0 Pillar One: Personalized, Lifetime Support and Education
Sep 07, 2023
HealthTree 2.0 Pillar One: Personalized, Lifetime Support and Education
Sep 07, 2023
From the Community: How the HealthTree Foundation Has Helped Our Lives
Sep 05, 2023
From the Community: How the HealthTree Foundation Has Helped Our Lives
Sep 05, 2023
John and Ann: Myeloma Pioneers
Sep 02, 2023
Blood Cancer Awareness Month: What To Expect
Sep 01, 2023
Blood Cancer Awareness Month: What To Expect
Sep 01, 2023
Blood Cancer Awareness Month: What To Expect
Sep 01, 2023
Blood Cancer Awareness Month: What To Expect
Sep 01, 2023
Understanding Thrombocytopenia in Myeloma
Aug 24, 2023
LBL-034: A New Option for Myeloma Patients in Clincal Trial Stage
Aug 24, 2023
Understanding Relapse In Multiple Myeloma
Aug 22, 2023
Why is a PET Scan Necessary in Myeloma?
Aug 21, 2023
What is Paresthesia in Myeloma?
Aug 17, 2023
$Elranatamab Receives FDA Accelerated Approval for Refractory/Relapsed Myeloma Treatment image$

Elranatamab Receives FDA Accelerated Approval for Refractory/Relapsed Myeloma Treatment
Aug 15, 2023
Blessed to Be Alive and Living: A Myeloma Patient Story
Aug 14, 2023
Talquetamab Approved for Myeloma Patients by FDA
Aug 10, 2023
Boston Myeloma Round Table on September 16th
Aug 10, 2023
A Promising New CAR-T Therapy on the Horizon
Aug 08, 2023
Dealing with Dialysis: A Myeloma Patient Story
Aug 04, 2023